Ziopharm Oncology (ZIOP) Reports Q3 Loss of $0.14/Share
Tweet
Share
E-mailGet Alerts ZIOP Hot Sheet
Join SI Premium – FREE
Ziopharm Oncology (NASDAQ: ZIOP) reported Q3 EPS of ($0.14), versus ($0.06) reported last year.
For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
- Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
